SILMO Paris attracted over 32,000 visitors from more than 130 countries, with 51% international attendance, making it one of the most important global gatherings for the optical industry. The Company's participation aligns with its strategic focus on international expansion, particularly as smart eyewear adoption accelerates in markets outside the United States, where pedestrian and public transit usage create ideal use cases for open-ear audio and AI assistance. Company Showcased at SILMO's Inaugural Smart ...

Core Viewpoint - Innovative Eyewear, Inc. has entered into definitive agreements for the immediate exercise of certain outstanding warrants, resulting in the issuance of new Series I warrants and expected gross proceeds of approximately $2.2 million from the transaction [1][4][10] Group 1: Warrant Inducement Transaction - The company will exercise warrants to purchase 746,782 shares at an exercise price of $2.60 per share, with the closing expected around June 24, 2025 [1] - In exchange for the immediate exercise of the warrants, the company will issue new unregistered Series I warrants to purchase up to 2,240,346 shares at a purchase price of $0.125 per warrant, generating approximately $0.3 million in gross proceeds [3] - The gross proceeds from the warrant inducement transaction are expected to be approximately $2.2 million before deducting fees and expenses [4] Group 2: Additional Warrant Exercises - Over the last 30 days, the company has received approximately $2.6 million from the exercise of certain warrants by investors, resulting in the purchase of 986,532 shares at the original exercise price of $2.60 per share [5][10] Group 3: Regulatory and Compliance Information - The new Series I warrants and the shares of common stock issuable upon their exercise are being offered in a private placement and have not been registered under the Securities Act of 1933 [6] - The company has agreed to file a registration statement with the SEC within 30 days covering the resale of the shares of common stock issuable upon exercise of the new Series I warrants [6]